Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
DexCom, Inc. - Common Stock
(NQ:
DXCM
)
82.92
-0.66 (-0.79%)
Streaming Delayed Price
Updated: 1:00 PM EDT, Jul 3, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about DexCom, Inc. - Common Stock
< Previous
1
2
...
7
8
9
10
11
12
13
14
15
...
35
36
Next >
DexCom Stock Plunged Over 40% Last Week. Are Eli Lilly's and Novo Nordisk's Drugs to Blame?
July 30, 2024
DexCom faces several challenges, but GLP-1 drugs aren't big problems for the company right now.
Via
The Motley Fool
Demystifying DexCom: Insights From 15 Analyst Reviews
July 29, 2024
Via
Benzinga
ON Semiconductor Posts Upbeat Earnings, Joins Oil States International, CommScope Holding And Other Big Stocks Moving Higher On Monday
July 29, 2024
Via
Benzinga
Behind the Scenes of DexCom's Latest Options Trends
July 29, 2024
Via
Benzinga
Despite its growth, NASDAQ:DXCM remains within the realm of affordability.
July 29, 2024
In the world of growth stocks, NASDAQ:DXCM shines as a value proposition.
Via
Chartmill
Why DexCom Stock Is Crashing Today
July 26, 2024
Investors are worried about the diabetes care technology leader's slowing growth.
Via
The Motley Fool
Tandem Diabetes Care and Dexcom Announce the t:slim X2 Insulin Pump with Dexcom G7 CGM Compatibility is Authorized for Sale by Health Canada
July 29, 2024
From
Tandem Diabetes Care, Inc.
Via
Business Wire
DXCM Is Being Investigated for Potential Securities Law Violations - Contact Kaplan Fox & Kilsheimer LLP
July 29, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
DXCM Is Being Investigated for Potential Securities Law Violations - Contact Kaplan Fox & Kilsheimer LLP
July 29, 2024
NEW YORK, NY - (NewMediaWire) - July 29, 2024 - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against DexCom, Inc. (DXCM) (“DexCom” or the “Company”) (NASDAQ: DXCM).
Via
TheNewswire.com
Is Beaten-Down Dexcom Stock a Buy on the Dip?
July 29, 2024
The market may have overreacted to a disappointing earnings report.
Via
The Motley Fool
2 Unstoppable Growth Stocks to Buy Right Now for Less Than $1,000
July 29, 2024
These profitable businesses have a lot to offer the long-term investor.
Via
The Motley Fool
Kaplan Fox & Kilsheimer LLP is Investigating Possible Securities Law Violations Against DexCom, Inc. (DXCM)
July 28, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Kaplan Fox & Kilsheimer LLP is Investigating Possible Securities Law Violations Against DexCom, Inc. (DXCM)
July 28, 2024
NEW YORK, NY - (NewMediaWire) - July 28, 2024 -- Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against DexCom, Inc. (DXCM) (“DexCom” or the “Company”) (NASDAQ: DXCM).
Via
TheNewswire.com
2 Magnificent Growth Stocks to Buy Right Now
July 27, 2024
These top stocks are looking increasingly attractive for a long-term investment.
Via
The Motley Fool
Kaplan Fox & Kilsheimer LLP is Investigating DexCom, Inc. (DXCM) for Potential Securities Law Violations
July 26, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Kaplan Fox & Kilsheimer LLP is Investigating DexCom, Inc. (DXCM) for Potential Securities Law Violations
July 26, 2024
NEW YORK, NY - (NewMediaWire) - July 26, 2024 - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against DexCom, Inc. (DXCM) (“DexCom” or the “Company”) (NASDAQ: DXCM).
Via
TheNewswire.com
DEXCOM ALERT: Bragar Eagel & Squire, P.C. is Investigating DexCom, Inc. on Behalf of DexCom Stockholders and Encourages Investors to Contact the Firm
July 26, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
DXCM INVESTIGATION ALERT: Robbins Geller Rudman & Dowd LLP Announces Investigation into DexCom, Inc. and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm
July 26, 2024
From
Robbins Geller Rudman & Dowd LLP
Via
Business Wire
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against DexCom, Inc. (DXCM)
July 26, 2024
From
Kirby McInerney LLP
Via
Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of DexCom, Inc. (DXCM) on Behalf of Investors
July 26, 2024
From
The Law Offices of Frank R. Cruz
Via
Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of DexCom, Inc. (DXCM) on Behalf of Investors
July 26, 2024
From
Glancy Prongay & Murray LLP
Via
Business Wire
S&P 500 Gains Over 1%; 3M Shares Jump After Q2 Results
July 26, 2024
Via
Benzinga
Topics
Stocks
Wall Street Enjoys Late-Week Rally On Benign Inflation Data, Dow Jones Eyes Best Session Of 2024, Tech Unwinding Stalls: What's Driving Markets Friday?
July 26, 2024
After a turbulent week in the markets, the bulls reclaimed dominance on Wall Street during Friday’s session, with indices and sectors trading in positive territory as investors welcomed the latest...
Via
Benzinga
Topics
Economy
Stocks
Dow Recovers Weekly Losses With 600-Point Pop
July 26, 2024
The Dow Jones Industrial Average is soaring today, up 608 points at last look and breaking into positive territory for the week.
Via
Talk Markets
Topics
Stocks
Why Saia Shares Are Trading Lower? Here Are Other Stocks Moving In Friday's Mid-Day Session
July 26, 2024
Via
Benzinga
DXCM Investors Have Opportunity to Join DexCom, Inc. Securities Fraud Investigation with the Schall Law Firm
July 26, 2024
From
The Schall Law Firm
Via
Business Wire
Crude Oil Down Over 2%; Bristol Myers Squibb Posts Upbeat Q2 Results
July 26, 2024
Via
Benzinga
DexCom Faces Short-Term Challenges, But Market Growth Prospects Remain Strong: Analyst
July 26, 2024
DexCom reports Q2 sales of $1.004B, up 15% YoY, with adjusted EPS of $0.43, beating the $0.39 consensus. Despite lowering 2024 sales guidance to $4.00-$4.05B, William Blair maintains an Outperform...
Via
Benzinga
Why DexCom Stock Is Trading Lower Friday
July 26, 2024
DexCom shares are trading lower Friday after the company reported worse-than-expected second quarter revenue and issued weak guidance.
Via
Benzinga
Kroger and Albertsons Pause Merger Deal: KR and ACI Stocks on Watch
July 26, 2024
Kroger and Albertsons are gearing up for a Colorado lawsuit that has put the combination of the two grocery companies on hold.
Via
InvestorPlace
Topics
Lawsuit
< Previous
1
2
...
7
8
9
10
11
12
13
14
15
...
35
36
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.